Pfizer (PFE) and Allogene Therapeutics Enter Pact for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio – StreetInsider.com
|
Pfizer (PFE) and Allogene Therapeutics Enter Pact for Pfizer's Allogeneic CAR T Immuno-oncology Portfolio
StreetInsider.com Pfizer Inc. (NYSE: PFE) and Allogene Therapeutics, Inc. (Allogene) today announced that the two companies have entered into an asset contribution agreement for Pfizer's portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR T … |
